Showing results (211-220 of 254) with videos related to
Sort By:
Pageof 26
Transplantation|January 22, 2009
Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trialFrancesco P Schena, Michael D Pascoe, Josefina Alberu, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|December 23, 2004
Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantationRainer Oberbauer, Giuseppe Segoloni, Josep M Campistol, et al.Journal of the American Society of Nephrology : JASN|January 26, 2006
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantationJosep M Campistol, Josette Eris, Rainer Oberbauer, et al.Transplantation|April 28, 2016
Diagnostic Contribution of Donor-Specific Antibody Characteristics to Uncover Late Silent Antibody-Mediated Rejection-Results of a Cross-Sectional Screening StudyFarsad Eskandary, Gregor Bond, Nicolas Kozakowski, et al.Frontiers in Immunology|October 21, 2022
Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipientsBilgin Osmanodja, Johannes Stegbauer, Marta Kantauskaite, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|August 30, 2021
Organ transplants of the future: planning for innovations including xenotransplantationEmanuele Cozzi, Stefan Schneeberger, Maria Irene Bellini, et al.Wiener Klinische Wochenschrift|April 26, 2023
[Diabetic kidney disease (update 2023) : Position paper of the Austrian Diabetes Association and the Austrian Society for Nephrology]Harald Sourij, Roland Edlinger, Friedrich C Prischl, et al.Ebiomedicine|July 12, 2024
Combination cell therapy leads to clonal deletion of donor-specific T cells in kidney transplant recipientsAna F David, Andreas Heinzel, Michael Kammer, et al.Transplantation Direct|March 21, 2020
High-activity Classical and Alternative Complement Pathway Genotypes-Association With Donor-specific Antibody-triggered Injury and Renal Allograft SurvivalBlanka Mező, Roman Reindl-Schwaighofer, Farsad Eskandary, et al.Journal of the American Society of Nephrology : JASN|December 16, 2017
A Randomized Trial of Bortezomib in Late Antibody-Mediated Kidney Transplant RejectionFarsad Eskandary, Heinz Regele, Lukas Baumann, et al.Pageof 26